Arcadia Biosciences
RKDA
12 hedge funds and large institutions have $5.11M invested in Arcadia Biosciences in 2016 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 5 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
1.07% less ownership
Funds ownership: 13.56% → 12.49% (-1.1%)
25% less funds holding
Funds holding: 16 → 12 (-4)
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
89% less capital inflows, than outflows
Capital inflows: $85.2K | Capital outflows: $770K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Virtu KCG Holdings
New York
|
+$65.9K |
| 2 |
Tower Research Capital (TRC)
New York
|
+$15.9K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.27K |
| 4 |
BlackRock Fund Advisors
San Francisco,
California
|
+$1.14K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Waddell & Reed Financial
Overland Park,
Kansas
|
-$720K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$19K |
| 3 |
Goldman Sachs
New York
|
-$10.2K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$7K |
RKDA Hedge Fund Activity: Q4 2016 in Review
12 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Arcadia Biosciences (RKDA) for Q4 2016, worth a combined $5.11M — down 56% from $11.6M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of RKDA and 1 opened new positions — a net loss of 4 holders — while 2 trimmed existing stakes and 3 added.
The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $65.9K. The largest seller was Waddell & Reed Financial, cutting an estimated $720K.
- 12 institutional investors held Arcadia Biosciences (RKDA) as of Q4 2016, down from 16 in Q3 2016.
- Funds reported $5.11M of Arcadia Biosciences stock for Q4 2016, down 56% quarter-over-quarter.
- 1 fund opened new Arcadia Biosciences positions in Q4 2016 and 5 closed out, a net change of -4 holders.
- The largest Arcadia Biosciences buyer in Q4 2016 was Virtu KCG Holdings, an estimated $65.9K added.
- The largest Arcadia Biosciences seller in Q4 2016 was Waddell & Reed Financial, an estimated $720K sold.
Based on aggregated 13F filings for Q4 2016.